CENTOGENE, Denali Partnering to Recruit LRRK2 Parkinson’s Patients for Clinical Trials
CENTOGENE and Denali Therapeutics are teaming up to identify and recruit Parkinson’s disease patients who carry mutations…
Articles by Diogo Pinto
Higher Mortality Rates Found in Patients with Parkinson’s Dementia, Lewy Body Dementia, Study Shows
Patients diagnosed with Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) were found to have a mortality…
Study Reveals Alpha-synuclein’s Role in Parkinson’s, Lewy Body Dementia
Alpha-synuclein (aSyn), a protein linked to Parkinson’s disease and dementia with Lewy bodies (DLB), exerts its harmful effects…
Michael J. Fox Foundation Offering $7.5M in Funding for Parkinson’s Research Projects
The Michael J. Fox Foundation is continuing to support the advancement of Parkinson’s disease research by investing up to…
Insulin Resistance Under-diagnosed in Non-Diabetic Parkinson’s Patients, Study Shows
Insulin resistance, a condition in which cells fail to respond normally to the hormone insulin, affects almost two-thirds of non-diabetic Parkinson’s…
Potential Parkinson’s Treatment, DNL201, Safe and Well-Tolerated in Phase 1 Study, Denali Says
Denali Therapeutics’ reports that its investigational compound for Parkinson’s disease, DNL201, was found to be safe and well-tolerated…
Researchers Receive Funding to Study New Gene Linked to Parkinson’s Disease
A multidisciplinary research team at Purdue University in Indiana and the University of Bordeaux in France was awarded a $107,000 grant by…